About RSV Immunoprophylaxis

RSV immunoprophylaxis helps protect eligible infants and children against severe illness caused by respiratory syncytial virus (RSV).

Beyfortus® (nirsevimab)

Beyfortus® (nirsevimab) is a long-acting monoclonal antibody that provides passive immunity against RSV. It is the primary RSV immunoprophylaxis product currently used in Alberta for eligible infants during the RSV season.

Note: The Government of Alberta will be offering Beyfortus® (nirsevimab) free-of-charge to all babies born in the hospital during RSV season (November through April). For more information, see Respiratory Syncytial Virus Vaccine.

Product Information

• Beyfortus® Product Monograph

Program Responsibilities

The Alberta Pediatric High Risk RSV Prevention Programs are responsible for:

• Assessing an infant's or child's eligibility for RSV immunoprophylaxis based on provincial eligibility criteria established by the program medical directors in collaboration with key stakeholders.
• Notifying referral sources of an infant's or child's eligibility or non-eligibility for RSV immunoprophylaxis.
• Coordinating access to RSV immunoprophylaxis products, including Beyfortus® (nirsevimab)
• Supporting the distribution of RSV immunoprophylaxis products to participating community clinics, hospitals, and other designated points of care.
• Connecting outpatient families with locations where RSV immunoprophylaxis can be administered.
• Providing education and support to healthcare providers, families, and community partners regarding RSV prevention strategies.

Eligibility Criteria & Referrals

Current season eligibility criteria and referral instructions are available through the Alberta Referral Directory (ARD).

Northern Alberta

Edmonton Zone & Area

• Northern Alberta Pediatric RSV Prevention Program

Southern Alberta

Alberta Children's Hospital

• Southern Alberta RSV Prevention Program

RSV Season

The start of seasonal RSV immunoprophylaxis in each region is determined by the program medical director based on local epidemiology, disease activity, and public health surveillance data.

In Alberta, RSV activity typically increases during the fall and winter months. However, the timing and duration of RSV circulation may vary from season to season.

Information regarding the start and end of the RSV prevention season, along with administration recommendations, will be communicated annually by the Alberta Pediatric High Risk RSV Prevention Programs.

Contact

Northern AB High Risk RSV Prevention Program

• Service Listing (contact info)
• Nurse Coordinator: Gail Porter-Lai RN
• Director: Dr. Carina Majaesic MD, PhD, FRCPC, Paediatric Respiralogist

Southern AB High Risk RSV Prevention Program

• Service Listing (contact info)
• Nurse Coordinator: Lisa Loczy RN, BN
• Director: Dr. Candice Bjornson MD MSc FRCPC, Paediatric Respiralogist